Paper19250190
Steroid hormone transforming aldo-keto reductases and cancer.
Penning TM and 1 other. Ann N Y Acad Sci, 2009. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Steroid hormone transforming aldo-keto reductases and cancer. Papers, record 19250190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19250190
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alcohol Oxidoreductases | Major topic |
| Androgens | Major topic |
| Breast Neoplasms | Major topic |
| Estrogens | Major topic |
| Isoenzymes | Major topic |
| Prostatic Neoplasms | Major topic |
| Aldehyde Reductase | |
| Aldo-Keto Reductases | |
| Breast | |
| Chromosome Mapping | |
| Enzyme Inhibitors | |
| Female | |
| Humans | |
| Hydroxyprostaglandin Dehydrogenases | |
| Male | |
| Prostate |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 ES013508 | NIEHS NIH HHS | United States | P30ES013508 | PubMed and NIH | NIH RePORTER |
| R01 CA090744 | NCI NIH HHS | United States | R01CA090744 | PubMed and NIH | NIH RePORTER |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16510604 | Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/16510604 | PubMed |
| 2 | 17950253 | An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies. | Biochem Pharmacol | 2008 | https://conductscience.org/library/papers/17950253 | PubMed |
| 3 | 16601286 | Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. | Endocr Relat Cancer | 2006 | https://conductscience.org/library/papers/16601286 | PubMed |
| 4 | 18045633 | Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition. | Steroids | 2008 | https://conductscience.org/library/papers/18045633 | PubMed |
| 5 | 8476772 | Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. | J Steroid Biochem Mol Biol | 1993 | https://conductscience.org/library/papers/8476772 | PubMed |
| 6 | 15582534 | Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. | Steroids | 2004 | https://conductscience.org/library/papers/15582534 | PubMed |
| 7 | 14672942 | Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14672942 | PubMed |
| 8 | 14979715 | Crystal structure of human prostaglandin F synthase (AKR1C3). | Biochemistry | 2004 | https://conductscience.org/library/papers/14979715 | PubMed |
| 9 | 11174850 | Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland. | J Mol Endocrinol | 2001 | https://conductscience.org/library/papers/11174850 | PubMed |
| 10 | 16338060 | AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. | Mol Cell Endocrinol | 2006 | https://conductscience.org/library/papers/16338060 | PubMed |
| 11 | 10625484 | Mutation of nicotinamide pocket residues in rat liver 3 alpha-hydroxysteroid dehydrogenase reveals different modes of cofactor binding. | Biochemistry | 2000 | https://conductscience.org/library/papers/10625484 | PubMed |
| 12 | 17145895 | 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/17145895 | PubMed |
| 13 | 6410393 | Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6410393 | PubMed |
| 14 | 16417966 | Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. | Mol Cell Endocrinol | 2006 | https://conductscience.org/library/papers/16417966 | PubMed |
| 15 | 9307009 | Comparative anatomy of the aldo-keto reductase superfamily. | Biochem J | 1997 | https://conductscience.org/library/papers/9307009 | PubMed |
| 16 | 17954234 | Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI/MS). | Methods Enzymol | 2007 | https://conductscience.org/library/papers/17954234 | PubMed |
| 17 | 18519708 | Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. | Cancer Res | 2008 | https://conductscience.org/library/papers/18519708 | PubMed |
| 18 | 9415401 | Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. | Mol Endocrinol | 1997 | https://conductscience.org/library/papers/9415401 | PubMed |
| 19 | 15047184 | Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. | Arch Biochem Biophys | 2004 | https://conductscience.org/library/papers/15047184 | PubMed |
| 20 | 11513593 | Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. | Biochemistry | 2001 | https://conductscience.org/library/papers/11513593 | PubMed |
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42518214 | 3beta-HSD1-mediated steroid back-conversion maintains androgen signaling in prostate cancer. | Mol Cancer Res | 2026 | https://conductscience.org/library/papers/42518214 | PubMed |
| 41898445 | Anabolic-Androgenic Steroids Revisited: Structural Biology, Receptor Signaling, and Mechanisms of Anabolic-Androgenic Dissociation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898445 | PubMed |
| 41735769 | Androgen metabolism in prostate cancer: recent advances. | Endocrinology | 2026 | https://conductscience.org/library/papers/41735769 | PubMed |
| 41318954 | Estrogen regulation in the prostate underlies racial disparity in men with benign prostatic hyperplasia. | J Pathol | 2026 | https://conductscience.org/library/papers/41318954 | PubMed |
| 40728694 | Per- and Polyfluoroalkyl Substances (PFAS) Enhance Cholesterol Accumulation and Dysregulate Inflammatory Responses in Macrophages. | Cardiovasc Toxicol | 2025 | https://conductscience.org/library/papers/40728694 | PubMed |
| 40721470 | Genetic and computational analysis of AKR1C4 gene rs17134592 polymorphism in breast cancer among the Bangladeshi population. | Sci Rep | 2025 | https://conductscience.org/library/papers/40721470 | PubMed |
| 40613036 | BLID is a drug-responsive target of FOXO3a and multi-omics analysis reveals survival mechanisms and therapeutic vulnerabilities in BLID-deficient breast cancer cells. | Oncol Lett | 2025 | https://conductscience.org/library/papers/40613036 | PubMed |
| 39272833 | Analysis of Expression and Regulation of AKR1C2 in HPV-Positive and -Negative Oropharyngeal Squamous Cell Carcinoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39272833 | PubMed |
| 39163853 | Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway. | Cell Chem Biol | 2025 | https://conductscience.org/library/papers/39163853 | PubMed |
| 39055885 | Aldo-keto reductases: Role in cancer development and theranostics. | Oncol Res | 2024 | https://conductscience.org/library/papers/39055885 | PubMed |
| 38947111 | Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases. | Yale J Biol Med | 2024 | https://conductscience.org/library/papers/38947111 | PubMed |
| 38890190 | AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation. | Cancer Chemother Pharmacol | 2024 | https://conductscience.org/library/papers/38890190 | PubMed |
| 38577596 | Defining the biological functions and clinical significance of AKR1C3 in gastric carcinogenesis through multiomics functional analysis and immune infiltration analysis. | J Cancer | 2024 | https://conductscience.org/library/papers/38577596 | PubMed |
| 38568856 | High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. | Environ Health Perspect | 2024 | https://conductscience.org/library/papers/38568856 | PubMed |
| 37428858 | Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model. | J Med Chem | 2023 | https://conductscience.org/library/papers/37428858 | PubMed |
| 37189628 | Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189628 | PubMed |
| 37107284 | Aldo-Keto Reductase 1C15 Characterization and Protection in Ischemic Brain Injury. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107284 | PubMed |
| 36794010 | Inhibition of castration-resistant prostate cancer growth by genistein through suppression of AKR1C3. | Food Nutr Res | 2023 | https://conductscience.org/library/papers/36794010 | PubMed |
| 36762781 | AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells. | J Breast Cancer | 2023 | https://conductscience.org/library/papers/36762781 | PubMed |
| 36623880 | Relevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone Disposition. | Drug Metab Dispos | 2023 | https://conductscience.org/library/papers/36623880 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19250190
GET https://conductscience.org/api/papers/v1/19250190/references?page=2